In the TRIUMPH-1 trial, Retatrutide showed more significant weight loss at high doses compared to results seen with Tirzepatide in separate studies
Melissa-Rosina Pasqua, an endocrinologist at the MUHC and a doctoral student at the Institute
The findings, which were presented at the 61st ERA Congress Friday, suggest that receiving a weekly injection of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may help prevent complications like chronic kidney disease and end-stage renal disease that often occur alongside obesity
Other Ingredients: Cellulose, hydroxypropyl, methylcellulose (capsule), vegetable stearate and silica
6 (5), e1000962
To stabilize the nano system, one or more than one surfactant can be used in a range of 1.5% to 5% (w/v) in a binary mix of solid and liquid lipids